| 1 |  Isomorphic Labs | $2.7B | 90 |
| 2 |  Treeline BiosciencesUS · est. 2021 | $1.1B | 63 |
| 3 |  Generate:BiomedicinesUnited States · est. 2018 | $700M | 77 |
| 4 |  Insilico MedicineUS | $510M | 55 |
| 5 |  RecursionUS · est. 2013 | $500M | 66 |
| 6 |  Pathos AI | $467M | 57 |
| 7 |  Paradigm HealthUS · est. 2023 | $359M | 65 |
| 8 |  OwkinFR · est. 2016 | $354M | 42 |
| 9 |  Genesis Therapeutics | $344M | 72 |
| 10 |  Genesis Molecular AIUS · est. 2019 | $280M | 57 |
| 11 |  Chai DiscoveryUS · est. 2023 | $200M | 46 |
| 12 |  Terray TherapeuticsUS · est. 2018 | $180M | 54 |
| 13 |  ProfluentUS · est. 2022 | $150M | 52 |
| 14 |  ProsciaUnited States · est. 2014 | $130M | 75 |
| 15 |  Superluminal Medicines | $120M | 51 |
| 16 |  RayTheraUS · est. 2021 | $110M | 50 |
| 17 |  Aqemia | $103M | 71 |
| 18 |  Ollin Biosciences | $100M | 60 |
| 19 |  Excelsior SciencesUS · est. 2023 | $95M | 53 |
| 20 |  ChemifyUnited Kingdom · est. 2022 | $93M | 69 |
| 21 |  Basecamp ResearchGB · est. 2019 | $85M | 54 |
| 22 |  Lindus HealthGB · est. 2021 | $78M | 59 |
| 23 |  BioptimusFR · est. 2024 | $76M | 58 |
| 24 |  Edison ScientificUS · est. 2025 | $70M | 59 |
| 25 |  AI ProteinsUS · est. 2021 | $59.7M | 54 |
| 26 |  NoetikUS · est. 2021 | $54M | 53 |
| 27 |  Cellular IntelligenceUnited States | $47M | 69 |
| 28 |  VerleyFR · est. 2021 | $45M | 51 |
| 29 |  ChemLexSG · est. 2022 | $45M | 56 |
| 30 |  Nabla BioUS · est. 2021 | $37M | 49 |
| 31 |  ApohaGB · est. 2023 | $36M | 55 |
| 32 |  Alchemab Therapeutics | $32M | 66 |
| 33 |  Converge BioUS · est. 2023 | $30.5M | 53 |
| 34 |  Tahoe Therapeutics | $30M | 69 |
| 35 |  Manas AIUS · est. 2024 | $24.6M | 57 |
| 36 |  MOA FoodtechES · est. 2020 | $20M | 53 |
| 37 |  AntiverseGB · est. 2017 | $18M | 46 |
| 38 |  Ensocell | $16.3M | 58 |
| 39 |  Axiom BioUnited States · est. 2023 | $15M | 67 |
| 40 |  Accipiter BiosciencesUnited States · est. 2025 | $12.7M | 68 |
| 41 |  PercepticGB · est. 2025 | $12M | 54 |
| 42 |  Adaptyv BioSwitzerland | $8M | 64 |
| 43 |  Reveal HealthTechUS · est. 2023 | $7.2M | 55 |
| 44 |  Living ModelsFR · est. 2024 | $7M | 51 |
| 45 |  BiomatterLT · est. 2019 | $7M | 48 |
| 46 |  Imperagen | $6.7M | 36 |
| 47 |  immunitoAI | $6.1M | 45 |
| 48 |  Bindwell | $6M | 54 |
| 49 |  TriallyUS · est. 2022 | $4.7M | 50 |
| 50 |  Yoneda LabsUnited States · est. 2023 | $4M | 67 |